About
NuvoBio develops peptide therapeutics using its proprietary AI-driven platform, DarwinAI, to rapidly design and optimize peptides with enhanced specificity and reduced off-target effects for various therapeutic applications.
Explore NuvoBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.